Skip to content

Clinical trials

Completed Phase 2 Retinitis Pigmentosa trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinitis Pigmentosa Phase: Phase 2 Status: Completed Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20072
20101
20112
20121
20141
20151
20161
20171
20191
20201
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Neurotech Pharmaceuticals3
jCyte, Inc2
Aldeyra Therapeutics, Inc.1
Columbia University1
Foundation Fighting Blindness1
Moorfields Eye Hospital NHS Foundation Trust1
Nanoscope Therapeutics Inc.1
Ospedale San Raffaele1
Radtke, Norman D., M.D.1
Retina Foundation of the Southwest1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinitis Pigmentosa16
Retinal Diseases5
Eye Diseases4
Eye Diseases, Hereditary2
Macular Edema2
Retinal Degeneration2
Central Serous Chorioretinopathy1
Cone-Rod Dystrophies1
Genetic Diseases, X-Linked1
Macular Degeneration1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.